Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • jetmanbash jetmanbash Dec 26, 2013 9:58 PM Flag

    Liver problems bring on CKD:

    Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury
    Hepatology, 12/24/2013

    Belcher JM, et al. – Acute kidney injury (AKI) is common in patients with cirrhosis and associated with significant mortality. The most common etiologies of AKI in this setting are pre–renal azotemia (PRA), acute tubular necrosis (ATN) and hepatorenal syndrome (HRS). Accurately distinguishing the etiology of AKI is critical as treatments differ markedly. Urinary biomarkers of kidney injury are elevated in patients with cirrhosis and AKI due to ATN. Incorporating biomarkers into clinical decision making has the potential to more accurately guide treatment by establishing which patients have structural injury underlying their AKI.

 
AEGR
2.85-0.12(-4.04%)Apr 29 4:00 PMEDT